TG Therapeutics Competitors and Similar CompaniesClear all
TG Therapeutics's competitors and similar companies include CSL Behring, Chiesi Group, Biogen and Cadila Pharmaceuticals.
 TG Therapeutics TG Therapeutics is a biopharmaceutical company, which develops agents for the treatment of hematologic malignancies and autoimmune disorders. |  Chiesi Group Chiesi Group (Gruppo Chiesi, also known as CHIESI Farmaceutici) is a company that researches, develops, produces, and commercializes therapeutic solutions. |  Biogen Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases. |  Cadila Pharmaceuticals Cadila Pharmaceuticals is a company that develops and manufactures medicines for patients. | ||
Founding Date | Founding Date 1993 | Founding Date 1904 | Founding Date 1935 | Founding Date 1978 | Founding Date 1951 |
Type | Type Public | Type Subsidiary | Type Subsidiary | Type Public | Type Private |
Tags | |||||
Locations | Locations New York, US HQ | Locations King of Prussia, US HQ Broadmeadows, AU Parkville, AU Parkville, AU Wien, AT Mechelen, BE see more | Locations Parma, IT HQ Melbourne, AU Wien, AT Machelen, BE Santana De Parnaíba, BR São Paulo, BR Sofia, BG see more | Locations Cambridge, US HQ Vicente López, AR Macquarie Park, AU Wien, AT Machelen, BE São Paul, BR Toronto, CA see more | |
Employees | Employees 15314% increase | Employees 7,5692% decrease | Employees 5,8541% increase | Employees 7,605 | Employees 8,5201% increase |
Valuation ($) | Valuation ($) 4 b | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 26.7 b | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $616.3m (FY, 2025) | Revenue (est.) $7.9b (FY, 2020) | Revenue (est.) €2.4b (Y, 2021) | Revenue (est.) $9.9b (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods $100.7m (FY, 2025) | Cost of goods N/A | Cost of goods N/A | Cost of goods $2.4b (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit $515.6m (FY, 2025) | Gross profit $4.5b (FY, 2020) | Gross profit N/A | Gross profit $7.5b (FY, 2025) | Gross profit N/A |
Net income | Net income $447.2m (FY, 2025) | Net income N/A | Net income N/A | Net income $1.3b (FY, 2025) | Net income N/A |
For sources of this data, please see the company profile
View Company Profiles
Chiesi Group
HQ
Parma, IT
Chiesi Group (Gruppo Chiesi, also known as CHIESI Farmaceutici) is a company that researches, develops, produces, and commercializes therapeutic solutions.
View companyBiogen
HQ
Cambridge, US
Employees
7,605
Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases.
View companyCadila Pharmaceuticals
HQ
Bavla, IN
Employees
8,520↑ 1% increase
Cadila Pharmaceuticals is a company that develops and manufactures medicines for patients.
View company